Skip to main content

Table 1 TNF and RANKL blockade differently alter local bone turnover in hTNF-transgenic mice

From: Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis

Mice

OcPm/BPm (%)

ObPm/BPm (%)

NOc/BPm (cells/mm)

NOb/BPm (cells/mm)

Untreated hTNFtg

    

   Subchondral bone erosion

26 ± 2

5 ± 2

13.5 ± 1.1

2.5 ± 0.8

   Cortical bone channels

22 ± 1

25 ± 2

9.5 ± 0.7

11.4 ± 1.0

   Endosteal bone surface

1 ± 1

4 ± 1

1.2 ± 0.2

1.4 ± 0.3

OPG-treated hTNFtg

    

   Subchondral bone erosion

1 ± 1

0

0.6 ± 0.4

0

   Cortical bone channels

1 ± 1

1 ± 1

0.4 ± 0.4

0.2 ± 0.2

   Endosteal bone surface

0

0

0

0

Anti-TNF treated hTNFtg

    

   Subchondral bone erosion

3 ± 3

36 ± 5

4.1 ± 1.2

48.3 ± 11.4

   Cortical bone channels

9 ± 2

43 ± 10

8.7 ± 3.3

26.1 ± 7,2

   Endosteal bone surface

1 ± 1

4 ± 1

2.5 ± 1.2

10.9 ± 5.4

  1. Results presented as the mean ± standard error of the mean. Paw sections of transgenic for human tumor necrosis factor (hTNFtg) mice treated for six weeks with a neutralizing antibody against TNF (anti-TNF) or osteoprotegerin (OPG) were stained for functional osteoclasts and osteoblasts. The fraction of bone surface covered by osteoclasts and osteoblasts (OcPm/BPm, ObPm/BPm) and the numbers of osteoclasts and osteoblasts per bone perimeter (NOc/BPm, NObPm) were assessed and allocated to three skeletal compartments.